Back
Philip Morris International, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Sell
49
PM
Philip Morris International, Inc.
Last Price:
$156.83
Seasonality Move:
2.62%
Buy
80
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.73
Seasonality Move:
11.35%
Sell
49
Philip Morris International, Inc. (PM)
is a Sell
Is Philip Morris International, Inc. a Buy, Sell or Hold?
-
The current Philip Morris International, Inc. [PM] share price is $156.84. The Score for PM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
PM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PM Stock Price Chart
What is Philip Morris International, Inc.'s stock price today?
-
The Philip Morris International, Inc. share price today is $156.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PM is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 29.6 | Buy |
| Relative Strength Index (14 RSI): | 55.73 | Buy |
| Chaikin Money Flow: | -15934137 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (150.82 - 157.5) | Buy |
| Bollinger Bands (100): | (152.29 - 165.83) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.77 | Buy |
| Relative Strength Index (14 RSI): | 85.1 | Buy |
| Chaikin Money Flow: | 991653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (219.01 - 220.61) | Buy |
| Bollinger Bands (100): | (55.63 - 178.69) | Buy |
PM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 155.44 | Buy |
| 20-day SMA: | 153.94 | Buy |
| 50-day SMA: | 153.87 | Buy |
| 200-day SMA: | 164.01 | Sell |
| 8-day EMA: | 83.36 | Buy |
| 20-day EMA: | 40.86 | Buy |
| 50-day EMA: | 17.82 | Buy |
| 200-day EMA: | 4.66 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.26 | Buy |
| 20-day SMA: | 220.14 | Buy |
| 50-day SMA: | 161.87 | Buy |
| 200-day SMA: | 73.76 | Buy |
| 8-day EMA: | 220.14 | Buy |
| 20-day EMA: | 210.53 | Buy |
| 50-day EMA: | 173.33 | Buy |
| 200-day EMA: | 94.53 | Buy |
Philip Morris International, Inc. Earnings Growth & PM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $0.80 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Philip Morris International, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||